Human vitreal prostaglandin levels and proliferative diabetic retinopathy.
about
Intravitreal vs. subtenon triamcinolone acetonide for the treatment of diabetic cystoid macular edema.Post-hypoxic constriction of retinal arterioles is impaired during nitric oxide and cyclo-oxygenase inhibition and in diabetic patients without retinopathy.The diameter response of retinal arterioles in diabetic maculopathy is reduced during hypoxia and is unaffected by the inhibition of cyclo-oxygenase and nitric oxide synthesis.Angiogenic and vasculogenic factors in the vitreous from patients with proliferative diabetic retinopathy.Diabetic macular edema, retinopathy and age-related macular degeneration as inflammatory conditionsComparison of the efficacy between an intravitreal and a posterior subtenon injection of triamcinolone acetonide for the treatment of diffuse diabetic macular edema.
P2860
Human vitreal prostaglandin levels and proliferative diabetic retinopathy.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Human vitreal prostaglandin levels and proliferative diabetic retinopathy.
@ast
Human vitreal prostaglandin levels and proliferative diabetic retinopathy.
@en
type
label
Human vitreal prostaglandin levels and proliferative diabetic retinopathy.
@ast
Human vitreal prostaglandin levels and proliferative diabetic retinopathy.
@en
prefLabel
Human vitreal prostaglandin levels and proliferative diabetic retinopathy.
@ast
Human vitreal prostaglandin levels and proliferative diabetic retinopathy.
@en
P2093
P356
P1476
Human vitreal prostaglandin levels and proliferative diabetic retinopathy.
@en
P2093
P2888
P356
10.1023/A:1017557600233
P577
2001-07-01T00:00:00Z
P6179
1046080512